Elton  Bahtiri

Dr. Elton Bahtiri


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2015 in Journal of Bone and Mineral Metabolism
Verified
Journal Article
Closed access
PDF file
EBElton Bahtiri
Elton Bahtiri
HIHilmi Islami
Hilmi Islami
RHRexhep Hoxha
Rexhep Hoxha
HQHasime Qorraj-Bytyqi
Hasime Qorraj-Bytyqi
SRSylejman Rexhepi
Sylejman Rexhepi
ÇKÇağla Karakulak
Çağla Karakulak

12 March 2018 in Open Access Macedonian Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
HQHasime Qorraj-Bytyqi
Hasime Qorraj-Bytyqi
RHRexhep Hoxha
Rexhep Hoxha
SSShemsedin Sadiku
Shemsedin Sadiku
IBIsmet H. Bajraktari
Ismet H. Bajraktari
MSMentor Sopjani
Mentor Sopjani
EBElton Bahtiri
Elton Bahtiri
BACKGROUND: Proton pump inhibitors (PPIs) represent the most widely prescribed antisecretory agents, but their prolonged use, may influence iron and vitamin B12 status, which could have important implications for clinical practice.AIM: We undertook this study aiming to investigate the association between PPIs use for 12 months and potential changes in iron and vitamin B12 status, as well as whether this potential association varies among four specific PPI drugs used in the study.METHODS: A total of 250 adult subjects were recruited into this study, of which 200 subjects were PPIs users while 50 subjects belonged to the control group. Serum iron, ferritin, vitamin B12, and homocysteine (Hcy) levels were measured before the start of the study and after 12 months. Mann - Whitney U test and Kruskal - Wallis test was used to compare the baseline characteristics of the study groups, while Wilcoxon test was used to analyse post - pre differences.RESULTS: Statistical analysis showed significant changes within PPIs group and specific PPIs subgroups between the two-time points in serum ferritin and vitamin B12 levels, respectively, while no significant changes in serum iron and homocysteine levels were shown. However, subsequent diagnosis of hypoferremia and hypovitaminosis B12 in the whole study sample at 12 months was established in only 3.8% and 2.9% of the subjects, respectively.CONCLUSION: PPIs use for 12 months did not result in clinically significant iron and/or vitamin B12 deficiency; thus, these findings argue routine screening under normal circumstances, although monitoring in elderly and malnourished may be of precious value.

1 January 2014 in Materia Socio Medica
Verified
Journal Article
Open access
RHRexhep Hoxha
Rexhep Hoxha
HIHilmi Islami
Hilmi Islami
HQHasime QorrajBytyqi
Hasime QorrajBytyqi
STShpetim Thaci
Shpetim Thaci
EBElton Bahtiri
Elton Bahtiri
Body weight and body mass index (BMI) are considered strong predictors of osteoporotic fractures, though optimal BMI levels remain unsettled. There are several studies conducted on women about the relationship between BMI and bone mineral density (BMD), and just a few so far on men. Therefore, the objective of current study was to analyze the relationship between weight and BMI and BMD measured in lumbar spine (L1-L4), femur neck and total hip in 64 men from Kosovo. This cross-sectional study included a population of 64 men divided into three BMI groups. Dual-energy X-ray absorptiometry (DEXA) measurements were done in all the study participants. Pearson's correlation analysis showed a significant positive correlation between weight and BMI and BMD in femur neck and in total hip, and a significant negative correlation between age and femur neck BMD. Age-adjusted linear regression analysis showed that weight and BMI had a significant positive association with BMD levels. Although the results show significant relationship between BMI and BMD, the negative relationship between age and femur neck BMD may serve as guidance to initiate early assessment of the BMD in this region as well as preventive measures of osteoporosis and fractures among ageing men population.

3 March 2017 in Turkish Journal of Gastroenterology
Verified
Journal Article
Closed access
EBElton Bahtiri
Elton Bahtiri
HIHilmi Islami
Hilmi Islami
RHRexhep Hoxha
Rexhep Hoxha
AGAfrim Gashi
Afrim Gashi
KTKujtim Thaci
Kujtim Thaci
HBHasime Qorraj Bytyqi
Hasime Qorraj Bytyqi
Proton pump inhibitors (PPIs) are a widely used class of drugs because of a generally acceptable safety profile. Among recently raised safety issues of the long-term use of PPIs is the increased risk of developing hypomagnesemia. As there have been very few prospective studies measuring serum magnesium levels before and after PPI therapy, we aimed to prospectively assess the potential association between PPI therapy for 12 months and the risk of hypomagnesemia as well as the incidence of new-onset hypomagnesemia during the study. In addition, the association of PPI therapy with the risk of hypocalcemia was assessed. The study included 250 patients with normal serum magnesium and total calcium levels, who underwent a long-term PPI treatment. Serum magnesium, total calcium, and parathormone (PTH) levels were measured at baseline and after 12 months. Of the 250 study participants, 209 completed 12 months of treatment and were included in the statistical analysis. The Wilcoxon signed rank test showed no statistically significant differences in serum magnesium levels between measurements at two different time points. However, there were statistically significant differences in serum total calcium and PTH levels in PPI users. Stable serum magnesium levels were demonstrated after 12 months and no association between PPI use and risk of hypomagnesemia was shown in the general population. Significant reductions of serum total calcium levels were demonstrated among PPI users; nevertheless, further research is required before recommending any serum calcium and PTH level monitoring in patients initiated on long-term PPI therapy.

1 January 2012 in Journal of Pharmacology and Pharmacotherapeutics
Verified
Journal Article
Open access
PDF file
HQHasime Qorraj-Bytyqi
Hasime Qorraj-Bytyqi
RHRexhep Hoxha
Rexhep Hoxha
SKShaip Krasniqi
Shaip Krasniqi
VKValon Kransiqi
Valon Kransiqi
EBElton Bahtiri
Elton Bahtiri
Objective: To investigate the prevalence of the major drug interactions in children and verify the rate and profile of drug interactions in hospitalized pediatric patients. Materials and Methods: A retrospective study was designed and data collected from the files of hospitalized children in Pulmonology, Nephrology, and Gastroenterology wards of a Pediatric Clinic, from July 1999 to 2004. Results: From the analyzed material, we detected 34 cases of interactions, of which 1 was pharmacodynamics interaction, 13 were pharmacokinetic interactions, and 20 of unknown mechanisms. According to the rate of significance, 4 cases were categorized in the first significance rate of interaction, 18 cases in the second significance rate, 1 case of the third significance rate, 4 cases of the fourth significance rate, and 7 cases of the fifth significance rate. According to onset of cases, 33 cases were of delayed onset, and according to severity of interactions, in 7 cases we noticed major severity interaction, in 19 cases moderate severity and in 8 cases minor severity. Conclusions: The presence of drug interactions is a permanent risk in the pediatric clinic. Then, we can conclude that continued education, computer system for prescriptions, pharmacotherapy monitoring of patients, and the pharmacist participation in the multidisciplinary team are some manners of improving the treatment to hospitalized patients.

29 February 2016
Verified
Journal Article
Closed access
EBElton Bahtiri
Elton Bahtiri
HIH Islami
H Islami
SRS Rexhepi
S Rexhepi
HQH Qorraj-Bytyqi
H Qorraj-Bytyqi
KTK Thaçi
K Thaçi
RHR Hoxha
R Hoxha